Universidad Peruana Cayetano Heredia

Diabetes in South and Central America: An update

Mostrar el registro sencillo del ítem

dc.contributor.author Aschner, Pablo
dc.contributor.author Aguilar-Salinas, Carlos
dc.contributor.author Aguirre, Loreto
dc.contributor.author Franco, Laercio
dc.contributor.author Gagliardino, Juan Jose
dc.contributor.author de Lapertosa, Sylvia Gorban
dc.contributor.author Seclen, Segundo
dc.contributor.author Vinocour, Mary
dc.date.accessioned 2022-01-04T20:29:56Z
dc.date.available 2022-01-04T20:29:56Z
dc.date.issued 2014
dc.identifier.uri https://hdl.handle.net/20.500.12866/10432
dc.description.abstract The estimated population of the South and Central America (SACA) Region is 467.6 million and 64% is in the age range of 20–79 years but the population pyramid and age distribution are changing. The average prevalence of diabetes in the Region is 8.0% and is expected to reach 9.8% by the year 2035. Prevalence is much lower in rural settings than in urban and the differences attributed to lifestyle changes may be a target for intervention. The indigenous population is a particularly vulnerable group needing special attention. On average, 24% of the adult cases with diabetes are undiagnosed but in some countries this is still as high as 50%. Health expenditure due to diabetes in the Region is around 9% of the global total. Inadequate glycemic control, defined as HbA1c >7%, is a strong predictor of chronic complications which increase resource use in the Region and less than half of the patients enrolled in diabetes care programmes are at target. Fifty percent or more of the adult population is overweight/obese and around one third of the adult population has metabolic syndrome using regional cutoffs for waist circumference. The number of people with IGT is almost equal to those with diabetes presenting an additional challenge for prevention. Children with type 1 diabetes represent only 0.2% of the total population with diabetes but the incidence may be increasing. In many places they have limited access to insulin, and even when available, it is not used appropriately. The available epidemiological data provide the background to act in developing national diabetes programmes which integrate diabetes care with cardiovascular prevention and promote diabetes prevention as well. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Diabetes Research and Clinical Practice
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Diabetes en_US
dc.subject South and Central America en_US
dc.subject Glycemic control en_US
dc.subject HbA1c en_US
dc.subject Prevalance en_US
dc.subject Impaired Glucose Tolerance en_US
dc.title Diabetes in South and Central America: An update en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.diabres.2013.11.010
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.18
dc.relation.issn 1872-8227


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas